Aarti Drugs Ltd is a well-known Indian pharmaceutical company. Aarti Drugs Share Price on NSE as of 23 August 2024 is 563.60 INR. On this page, you will find Aarti Drugs Share Price Target 2024, 2025, 2026, 2027 to 2030 as well as Aarti Drugs latest News, Aarti Drugs share News, Why Aarti Drugs share falling, Aarti drugs share price target tomorrow, Aarti drugs share price target 2030, and more Information.
Aarti Drugs Ltd. Company Details
Aarti Drugs Ltd is a well-known Indian pharmaceutical company that specializes in manufacturing active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals. Established in 1984, Aarti Drugs has grown to be a trusted name in the industry, serving both domestic and international markets.
The company focuses on producing high-quality products that meet global standards, with a range that includes antibiotics, anti-diabetic, anti-inflammatory, and cardiovascular drugs. Aarti Drugs is dedicated to innovation, quality, and customer satisfaction, making it a reliable partner in the healthcare sector.
Official Website | aartidrugs.co.in |
Headquarters | India |
Number of employees | 1,003 (2023) |
Subsidiaries | Pinnacle Life Science Pvt. Ltd, Pinnacle Chile SpA, Suyash Laboratories Ltd. |
Category | Share Price |
Current Market Overview of Aarti Drugs Share Price
- Open:Â 566.00 INR
- High:Â 566.80 INR
- Low:Â 550.10 INR
- Market Cap: 5.18K Cr
- P/E Ratio: 33.06
- Dividend Yield:Â 0.18%
- 52-Week High:Â 625.00 INR
- 52-Week Low:Â 431.05 INR
Aarti Drugs Share Price Recent Graph
Read Also:- AFFLE India Share Price Target 2024, 2025 to 2030 and More Details
Aarti Drugs Share Price Target Tomorrow From 2024 to 2030
Here are the estimated share prices of Aarti Drugs for the upcoming years, based solely on market valuation, enterprise trends and professional predictions.
S. No. | Aarti Drugs Share Price Target Years | SHARE PRICE TARGETÂ |
1 | Aarti Drugs Share Price Target 2024 | ₹649 |
2 | Aarti Drugs Share Price Target 2025 | ₹911 |
3 | Aarti Drugs Share Price Target 2026 | ₹1042 |
4 | Aarti Drugs Share Price Target 2027 | ₹1191 |
5 | Aarti Drugs Share Price Target 2028 | ₹1363 |
6 | Aarti Drugs Share Price Target 2029 | ₹1559 |
7 | Aarti Drugs Share Price Target 2030 | ₹1785 |
Shareholding Pattern For Aarti Drugs Share Price
- Promoters:Â 55.67% (reduced from 57.13%)
- Retail and Others:Â 34.02%
- Mutual Funds:Â 5.70% (accelerated from 5.08%)
- Foreign Institutions:Â 2.96% (increased from 2.56%)
- Other Domestic Institutions:Â 1.65%
Major Factors Affecting Aarti Drugs Share Price
-
Product Demand: Aarti Drugs’ share price is closely tied to the demand for its pharmaceutical products, both domestically and internationally. Strong demand for their key drugs can lead to higher sales and boost the stock price.
- Regulatory Approvals: Obtaining approvals from regulatory bodies like the FDA and WHO for their drugs can positively impact the share price, as these approvals validate the quality and safety of their products.
- Raw Material Costs: Fluctuations in the cost of raw materials used in drug manufacturing can significantly influence profit margins. Lower raw material costs can increase profitability, positively affecting the share price.
- Expansion and Innovation: Aarti Drugs’ efforts in expanding its production capacity and investing in research and development for new drugs can lead to future growth, making the stock more attractive to investors.
-
Global Market Trends: Changes in the global pharmaceutical industry, including shifts in healthcare policies, market competition, and economic conditions, can impact Aarti Drugs’ share price. Staying competitive and adapting to market trends is crucial for the company’s stock performance.
Read Also:-
- MRPL Share Price Target
- BOI Share Price Target
- JBM Auto Share Price Target
- Thermax Limited Share Price Target
I am Ankita Vasishtha, passionate about trading and deeply committed to sharing my knowledge and insights with individuals like you. With a solid understanding of market dynamics and a knack for identifying trends, I strive to empower you with the information you need to thrive in trading.